Doctors are fomenting a different sort of rebellion against the interwoven mesh of drug company-doctor relationships. Medical societies long dependent on Pharma funding, such as the American College of Rheumatology, are trying to wean themselves. Prominent med schools are curtailing or downright prohibiting payments to doctors from drug reps. Longtime critics of the practice--such as Dr. Charles Brody of the University of Texas--say there's been a "sea change." Whether it will fully turn the tide remains to be seen.
- read the report from The Los Angeles Times